Aug 10, 2026 06:34AM
Jun 10, 2026 07:55AM
May 20, 2026 07:00AM
May 20, 2026 07:00AM
Apr 24, 2026 08:01AM
Apr 24, 2026 08:00AM
Apr 6, 2026 07:01AM Scinai completes reorganization, creates dedicated CDMO subsidiary
Apr 6, 2026 07:00AM
Apr 1, 2026 07:35AM
Mar 19, 2026 07:50AM
Mar 2, 2026 09:20AM
Mar 2, 2026 09:20AM
Feb 25, 2026 08:12AM
Feb 25, 2026 08:11AM Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform
Feb 17, 2026 07:00AM
Jan 7, 2026 07:00AM
Dec 2, 2025 08:55AM
Dec 2, 2025 08:50AM
Oct 6, 2025 07:31AM
Oct 6, 2025 07:30AM
Sep 2, 2025 07:30AM Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet
Jul 29, 2025 07:16AM
Jul 29, 2025 07:15AM
Jun 26, 2025 07:37AM
Jun 12, 2025 08:00AM
Jun 5, 2025 09:01AM
Jun 5, 2025 09:00AM
May 30, 2025 07:00AM Scinai Reports Q1 2025 Financial Results Highlighting Strong CDMO Revenue Momentum and Reduced Cash Burn
May 7, 2025 04:01PM
May 1, 2025 07:00AM
Mar 27, 2025 09:27AM
Mar 27, 2025 09:25AM
Mar 17, 2025 07:00AM
Mar 5, 2025 07:32AM
Mar 5, 2025 07:30AM SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT
Jan 6, 2025 07:31AM
Dec 16, 2024 09:25AM
Dec 5, 2024 08:25AM
Nov 27, 2024 08:00AM
Nov 22, 2024 07:15AM
Oct 31, 2024 06:59AM
Sep 16, 2024 07:00AM Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies
Aug 29, 2024 06:32AM
Aug 29, 2024 06:31AM
Aug 21, 2024 08:45AM
Aug 15, 2024 07:00AM
Aug 13, 2024 07:55AM
Aug 13, 2024 07:00AM
Jul 23, 2024 07:00AM Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the PEI on the path for Phase 1/2a in Plaque Psoriasis with its anti-IL-17 nanoAb
Jul 15, 2024 07:02AM

1,178,410 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All